LGALS1 and cervical squamous cell carcinoma: In the present study, we first examined the correlation between the expression of galectin-1 and integrin α5β1 and the responses to cisplatin-based NACT in patients with stage IB2 or IIA2 squamous cervical cancer, and then explored their potential mechanism(s) using the The Cancer Genome Atlas (TCGA) and GEO RNA-sequencing data.